• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Seroprevalence of SARS-CoV-2 IgG Antibodies in Children Hospitalized for Reasons Other Than COVID-19.因非新冠病毒肺炎(COVID-19)相关原因住院儿童中SARS-CoV-2 IgG抗体的血清流行率
J Clin Med. 2022 Jul 1;11(13):3819. doi: 10.3390/jcm11133819.
2
Seroprevalance of anti-SARS-CoV-2 antibodies in the IgG class in hospitalized children in the north-eastern part of Poland in 2021.2021 年波兰东北部住院儿童 IgG 类抗 SARS-CoV-2 抗体的血清阳性率。
Przegl Epidemiol. 2023;77(2):153-162. doi: 10.32394/pe.77.15.
3
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Children in Vietnam: An Observational, Hospital-Based Study.越南儿童中抗SARS-CoV-2抗体的高血清阳性率:一项基于医院的观察性研究。
Pathogens. 2022 Nov 30;11(12):1442. doi: 10.3390/pathogens11121442.
4
Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).儿童多系统炎症综合征(MIS-C)中 SARS-CoV-2 血清学的定量分析。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-018242. Epub 2020 Sep 2.
5
Healthcare workers highly affected during the COVID-19 epidemic wave in Poland prior to vaccination availability: seroprevalence study.在波兰有疫苗可用之前,新冠疫情期间受影响严重的医护人员:血清流行率研究。
Med Pr. 2022 Apr 22;73(2):109-123. doi: 10.13075/mp.5893.01216. Epub 2022 Mar 17.
6
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
7
Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.西班牙6000多名医护人员中新型冠状病毒2型抗体的血清阳性率
Int J Epidemiol. 2021 May 17;50(2):400-409. doi: 10.1093/ije/dyaa277.
8
Antibody Responses to SARS-CoV-2 in Children With COVID-19.儿童 COVID-19 患者对 SARS-CoV-2 的抗体反应。
J Pediatric Infect Dis Soc. 2022 Jun 22;11(6):267-273. doi: 10.1093/jpids/piac012.
9
High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.刚果共和国布拉柴维尔的无症状刚果人群中 SARS-CoV-2 IgG/IGM 高血清阳性率。
Int J Infect Dis. 2021 May;106:3-7. doi: 10.1016/j.ijid.2020.12.065. Epub 2020 Dec 25.
10
Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.加拿大蒙特利尔地区学校和日托中心儿童中 SARS-CoV-2 抗体的血清阳性率。
JAMA Netw Open. 2021 Nov 1;4(11):e2135975. doi: 10.1001/jamanetworkopen.2021.35975.

引用本文的文献

1
Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025.2025年波兰流行病学家和传染病学家协会新型冠状病毒2感染管理临床实践指南
J Clin Med. 2025 Mar 27;14(7):2305. doi: 10.3390/jcm14072305.
2
Has COVID-19 Affected the Course of Chickenpox in Children?新冠病毒是否影响了儿童水痘的病程?
Viruses. 2024 Dec 13;16(12):1912. doi: 10.3390/v16121912.
3
Three-year Seroprevalence of SARS-CoV-2 Nucleocapsid Protein Antibody Among Children, Parental Awareness, and Contributors of Infection: A Single-school Cohort Study in Chiba, Japan.日本千叶单校队列研究:儿童中SARS-CoV-2核衣壳蛋白抗体的三年血清流行率、家长认知及感染因素
J Epidemiol. 2025 Jun 5;35(6):278-286. doi: 10.2188/jea.JE20240284. Epub 2025 Feb 28.
4
Impact of COVID-19 Pandemic on the Clinical Course and Complications of Varicella-A Retrospective Cohort Study.2019冠状病毒病大流行对水痘临床病程及并发症的影响——一项回顾性队列研究
Pediatr Rep. 2024 Jun 4;16(2):451-460. doi: 10.3390/pediatric16020039.
5
SARS-CoV-2 Seroprevalence in Children under 5 Years Old-A Regional Seroepidemiological Study.SARS-CoV-2 血清流行率在 5 岁以下儿童中-一项区域性血清流行病学研究。
Medicina (Kaunas). 2024 Feb 24;60(3):384. doi: 10.3390/medicina60030384.
6
Differences in Clinical Presentation of COVID-19 in Children Hospitalized During Domination of Early (BA.1, BA.2) and Late (BA.5, BA.2.75, BQ.1 and XBB.1.5) SARS-CoV-2 Omicron Subvariants.奥密克戎变异株早期(BA.1、BA.2)和晚期(BA.5、BA.2.75、BQ.1 和 XBB.1.5)流行期间住院儿童 COVID-19 临床表现的差异。
Pediatr Infect Dis J. 2024 Feb 1;43(2):149-154. doi: 10.1097/INF.0000000000004167. Epub 2023 Nov 3.
7
Clinical Course and Severity of COVID-19 in 940 Infants with and without Comorbidities Hospitalized in 2020 and 2021: The Results of the National Multicenter Database SARSTer-PED.2020年和2021年住院的940名有或无合并症婴儿的COVID-19临床病程及严重程度:国家多中心数据库SARSTer-PED的结果
J Clin Med. 2023 Mar 24;12(7):2479. doi: 10.3390/jcm12072479.
8
SARS-CoV-2 seroprevalence among children in Latvia: A cross-sectional study.拉脱维亚儿童中 SARS-CoV-2 血清流行率:一项横断面研究。
Medicine (Baltimore). 2023 Feb 10;102(6):e32795. doi: 10.1097/MD.0000000000032795.

本文引用的文献

1
COVID-19 infections in infants.婴儿 COVID-19 感染。
Sci Rep. 2022 May 11;12(1):7765. doi: 10.1038/s41598-022-11068-0.
2
Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021.2020 年 3 月至 2021 年 12 月期间,18 岁以下儿童中急性 COVID-19 的严重程度。
Pediatrics. 2022 Apr 1;149(4). doi: 10.1542/peds.2021-055765.
3
Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.0-4 岁确诊感染 COVID-19 的婴幼儿住院情况-COVID-NET,14 个州,2020 年 3 月-2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):429-436. doi: 10.15585/mmwr.mm7111e2.
4
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis.五岁以下幼儿 COVID-19 感染的流行病学:系统评价和荟萃分析。
Vaccine. 2021 Jan 22;39(4):667-677. doi: 10.1016/j.vaccine.2020.11.078. Epub 2020 Dec 5.
5
Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.纽约市一家儿童医院的 2019 年冠状病毒病(COVID-19)患者的流行病学、临床特征和疾病严重程度。
JAMA Pediatr. 2020 Oct 1;174(10):e202430. doi: 10.1001/jamapediatrics.2020.2430. Epub 2020 Oct 5.
6
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.2019 年冠状病毒病在儿童中的情况-美国,2020 年 2 月 12 日至 4 月 2 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):422-426. doi: 10.15585/mmwr.mm6914e4.
7
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends.新型冠状病毒肺炎的体外诊断检测:最新进展与新趋势
Diagnostics (Basel). 2020 Apr 5;10(4):202. doi: 10.3390/diagnostics10040202.
8
COVID-19 epidemic: Disease characteristics in children.COVID-19 疫情:儿童疾病特征。
J Med Virol. 2020 Jul;92(7):747-754. doi: 10.1002/jmv.25807. Epub 2020 Apr 15.
9
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020.新型冠状病毒肺炎(SARS-CoV-2)感染的管理:波兰流行病学家和传染病学家协会截至2020年3月31日的建议
Pol Arch Intern Med. 2020 Apr 30;130(4):352-357. doi: 10.20452/pamw.15270. Epub 2020 Mar 31.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.

因非新冠病毒肺炎(COVID-19)相关原因住院儿童中SARS-CoV-2 IgG抗体的血清流行率

The Seroprevalence of SARS-CoV-2 IgG Antibodies in Children Hospitalized for Reasons Other Than COVID-19.

作者信息

Franczak Justyna, Moppert Justyna, Sobolewska-Pilarczyk Małgorzata, Pawłowska Małgorzata

机构信息

Department of Paediatrics, Infectious Diseases and Hepatology, Voivodeship Infectious Observation Hospital in Bydgoszcz, 85-030 Bydgoszcz, Poland.

Department of Infectious Diseases and Hepatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 87-100 Toruń, Poland.

出版信息

J Clin Med. 2022 Jul 1;11(13):3819. doi: 10.3390/jcm11133819.

DOI:10.3390/jcm11133819
PMID:35807103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267741/
Abstract

The aim of the study was to assess the seroprevalence of SARS-CoV-2 IgG antibodies in children hospitalized for reasons other than COVID-19. The study was conducted among 686 children, aged 2 weeks to 18 years, hospitalized in the Department of Paediatrics, Infectious Diseases, and Hepatology in Bydgoszcz, Poland, in the period from 1 June 2021 to 30 April 2022. The presence of anti-SARS-CoV-2 antibodies was detected in 392 (57%) children. Since December 2021, a significantly larger proportion of children with a positive titer of anti-SARS-CoV-2 antibodies has been observed, constituting as much as 87.5% of patients hospitalized in April 2022. In total, 69% of children with detected anti-SARS-CoV-2 antibodies were children under 5 years of age. The highest mean amounts of titers of anti-SARS-CoV-2 antibodies were observed in children over 10 years of age. The conducted studies showed the presence of anti-SARS-CoV-2 antibodies in a significant group of hospitalized children and an increase in the percentage of these children during the fourth and fifth wave of COVID-19 in Poland caused by the Delta and Omicron variants, respectively. The vast majority of parents of the studied children had no knowledge of the COVID-19 infection in their charges, which may indicate asymptomatic infection or mild course of the disease.

摘要

该研究的目的是评估因非新冠病毒疾病住院的儿童中新冠病毒2型免疫球蛋白G(SARS-CoV-2 IgG)抗体的血清流行率。该研究在2021年6月1日至2022年4月30日期间,对波兰比得哥什市儿科、传染病和肝病科收治的686名年龄在2周至18岁的儿童进行。在392名(57%)儿童中检测到抗SARS-CoV-2抗体。自2021年12月以来,观察到抗SARS-CoV-2抗体滴度呈阳性的儿童比例显著增加,在2022年4月住院的患者中占比高达87.5%。在检测到抗SARS-CoV-2抗体的儿童中,共有69%为5岁以下儿童。10岁以上儿童的抗SARS-CoV-2抗体平均滴度最高。所开展的研究表明,在一组住院儿童中存在抗SARS-CoV-2抗体,并且在波兰分别由德尔塔和奥密克戎变种引发的新冠疫情第四波和第五波期间,这些儿童的比例有所增加。所研究儿童的绝大多数家长对其子女感染新冠病毒并不知情,这可能表明存在无症状感染或疾病病程较轻。